TreeWAS – Variant ID: rs61770499

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability
Chapter XIX Injury, poisoning and certain other consequences of external causes	1.000	0.000
# Top node	1.000	0.000
Chapter XX External causes of morbidity and mortality	0.997	0.003
T36-T50 Poisoning by drugs, medicaments and biological substances	0.995	0.005
Chapter XIV Diseases of the genitourinary system	0.987	0.013
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use	0.979	0.021
Chapter I Certain infectious and parasitic diseases	0.977	0.023
N17-N19 Renal failure	0.977	0.023
N18 Chronic renal failure	0.974	0.026
S50-S59 Injuries to the elbow and forearm	0.963	0.037
S40-S49 Injuries to the shoulder and upper arm	0.956	0.044
N18.3 Chronic kidney disease, stage 3	0.956	0.044
Chapter V Mental and behavioural disorders	0.955	0.045
T51-T65 Toxic effects of substances chiefly nonmedicinal as to source	0.954	0.046
S90-S99 Injuries to the ankle and foot	0.948	0.052
Chapter VIII Diseases of the ear and mastoid process	0.947	0.053
A30-A49 Other bacterial diseases	0.942	0.058
N18.9 Chronic renal failure, unspecified	0.937	0.063
T51 Toxic effect of alcohol	0.931	0.069
Chapter IX Diseases of the circulatory system	0.929	0.071
H80-H83 Diseases of inner ear	0.927	0.073
Chapter XVII Congenital malformations, deformations and chromosomal abnormalities	0.922	0.077
Chapter II Neoplasms	0.922	0.078
N40-N51 Diseases of male genital organs	0.919	0.081
F30-F39 Mood [affective] disorders	0.919	0.081
I60-I69 Cerebrovascular diseases	0.916	0.084
B00-B09 Viral infections characterized by skin and mucous membrane lesions	0.914	0.086
T51.0 Ethanol	0.907	0.093
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism	0.903	0.097
S92 Fracture of foot, except ankle	0.899	0.101
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.896	0.104
N18.0 End-stage renal disease	0.895	0.105
S51 Open wound of forearm	0.895	0.105
N60-N64 Disorders of breast	0.890	0.110
X60-X84 Intentional self-harm	0.888	0.112
T46 Poisoning by agents primarily affecting the cardiovascular system	0.887	0.113
C45-C49 Malignant neoplasms of mesothelial and soft tissue	0.886	0.114
I67 Other cerebrovascular diseases	0.885	0.115
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue	0.885	0.115
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.882	0.118
N50 Other disorders of male genital organs	0.882	0.118
Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism	0.881	0.119
I65 Occlusion and stenosis of precerebral arteries, not resulting in cerebral infarction	0.881	0.119
D37-D48 Neoplasms of uncertain or unknown behaviour	0.879	0.121
T66-T78 Other and unspecified effects of external causes	0.878	0.122
H81 Disorders of vestibular function	0.876	0.124
H83 Other diseases of inner ear	0.871	0.129
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.871	0.129
V40-V49 Car occupant injured in transport accident	0.871	0.129
I67.8 Other specified cerebrovascular diseases	0.867	0.133
C45 Mesothelioma	0.862	0.138
Q60-Q64 Congenital malformations of the urinary system	0.861	0.139
T79-T79 Certain early complications of trauma	0.859	0.141
A41 Other septicaemia	0.857	0.143
B35-B49 Mycoses	0.852	0.148
C00-C14 Malignant neoplasms of lip, oral cavity and pharynx	0.851	0.149
I65.2 Occlusion and stenosis of carotid artery	0.851	0.149
N50.8 Other specified disorders of male genital organs	0.847	0.153
F33 Recurrent depressive disorder	0.844	0.156
T20-T25 Burns and corrosions of external body surface, specified by site	0.843	0.157
Chapter XVIII Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified	0.841	0.159
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.840	0.160
H81.1 Benign paroxysmal vertigo	0.840	0.160
S42 Fracture of shoulder and upper arm	0.840	0.160
S49 Other and unspecified injuries of shoulder and upper arm	0.839	0.161
R20.8 Other and unspecified disturbances of skin sensation	0.839	0.161
Q61 Cystic kidney disease	0.831	0.169
H83.0 Labyrinthitis	0.831	0.169
B02 Zoster [herpes zoster]	0.830	0.170
N00-N08 Glomerular diseases	0.830	0.170
X58-X59 Accidental exposure to other and unspecified factors	0.830	0.170
N42 Other disorders of prostate	0.829	0.171
A41.5 Septicaemia due to other Gram-negative organisms	0.829	0.171
R20 Disturbances of skin sensation	0.829	0.171
R20-R23 Symptoms and signs involving the skin and subcutaneous tissue	0.828	0.172
S50 Superficial injury of forearm	0.827	0.173
C45.0 Mesothelioma of pleura	0.822	0.178
Y51 Drugs primarily affecting the autonomic nervous system	0.821	0.179
T40.2 Other opioids	0.821	0.179
F32 Depressive episode	0.820	0.180
D47 Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue	0.819	0.181
W00-W19 Falls	0.814	0.186
V01-V09 Pedestrian injured in transport accident	0.810	0.190
S80-S89 Injuries to the knee and lower leg	0.809	0.191
N63 Unspecified lump in breast	0.806	0.194
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.806	0.194
I60 Subarachnoid haemorrhage	0.805	0.195
I95-I99 Other and unspecified disorders of the circulatory system	0.805	0.195
A00-A09 Intestinal infectious diseases	0.803	0.197
F80-F89 Disorders of psychological development	0.801	0.199
F10-F19 Mental and behavioural disorders due to psychoactive substance use	0.801	0.199
R40-R46 Symptoms and signs involving cognition, perception, emotional state and behaviour	0.799	0.201
S43 Dislocation, sprain and strain of joints and ligaments of shoulder girdle	0.798	0.202
R47-R49 Symptoms and signs involving speech and voice	0.798	0.202
Y54.5 Other diuretics	0.798	0.202
N10-N16 Renal tubulo-interstitial diseases	0.797	0.203
N64 Other disorders of breast	0.793	0.207
S41 Open wound of shoulder and upper arm	0.791	0.208
X40-X49 Accidental poisoning by and exposure to noxious substances	0.791	0.209
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.791	0.209
C85 Other and unspecified types of non-Hodgkin's lymphoma	0.790	0.210
V20-V29 Motorcycle rider injured in transport accident	0.790	0.210
C92 Myeloid leukaemia	0.788	0.212
T43.0 Tricyclic and tetracyclic antidepressants	0.783	0.217
I80-I89 Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified	0.781	0.219
Y43 Primarily systemic agents	0.780	0.220
Y60-Y69 Misadventures to patients during surgical and medical care	0.779	0.221
C81 Hodgkin's disease	0.779	0.221
S90 Superficial injury of ankle and foot	0.779	0.221
T90-T98 Sequelae of injuries, of poisoning and of other consequences of external causes	0.779	0.221
R47 Speech disturbances, not elsewhere classified	0.779	0.221
S53 Dislocation, sprain and strain of joints and ligaments of elbow	0.778	0.222
C73-C75 Malignant neoplasms of thyroid and other endocrine glands	0.777	0.223
Q61.2 Polycystic kidney, adult type	0.777	0.223
Y40 Systemic antibiotics	0.773	0.227
S92.2 Fracture of other tarsal bone(s)	0.773	0.227
Y48 Anaesthetics and therapeutic gases	0.772	0.228
S92.3 Fracture of metatarsal bone	0.771	0.229
T00-T07 Injuries involving multiple body regions	0.769	0.231
V10-V19 Pedal cyclist injured in transport accident	0.765	0.235
S70-S79 Injuries to the hip and thigh	0.765	0.235
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs	0.764	0.235
D65-D69 Coagulation defects, purpura and other haemorrhagic conditions	0.764	0.236
R47.8 Other and unspecified speech disturbances	0.764	0.236
S51.8 Open wound of other parts of forearm	0.762	0.238
B50-B64 Protozoal diseases	0.761	0.239
S92.0 Fracture of calcaneus	0.760	0.240
N46 Male infertility	0.760	0.240
T79 Certain early complications of trauma, not elsewhere classified	0.758	0.242
N49 Inflammatory disorders of male genital organs, not elsewhere classified	0.757	0.242
S49.9 Unspecified injury of shoulder and upper arm	0.756	0.244
B65-B83 Helminthiases	0.755	0.245
N03 Chronic nephritic syndrome	0.755	0.245
A46 Erysipelas	0.755	0.245
A49 Bacterial infection of unspecified site	0.754	0.246
S80 Superficial injury of lower leg	0.753	0.247
S51.7 Multiple open wounds of forearm	0.750	0.250
T51.9 Alcohol, unspecified	0.749	0.251
R80-R82 Abnormal findings on examination of urine, without diagnosis	0.749	0.251
A04 Other bacterial intestinal infections	0.748	0.252
Y00-Y09 Assault	0.747	0.253
N18.8 Other chronic renal failure	0.747	0.253
S30-S39 Injuries to the abdomen, lower back, lumbar spine and pelvis	0.746	0.254
Q65-Q79 Congenital malformations and deformations of the musculoskeletal system	0.746	0.254
B02.9 Zoster without complication	0.746	0.254
A48 Other bacterial diseases, not elsewhere classified	0.745	0.255
D37 Neoplasm of uncertain or unknown behaviour of oral cavity and digestive organs	0.745	0.255
Q61.3 Polycystic kidney, unspecified	0.744	0.256
N50.0 Atrophy of testis	0.742	0.258
I85 Oesophageal varices	0.741	0.259
N25-N29 Other disorders of kidney and ureter	0.740	0.260
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.739	0.261
F10 Mental and behavioural disorders due to use of alcohol	0.738	0.262
S20-S29 Injuries to the thorax	0.738	0.262
D55-D59 Haemolytic anaemias	0.737	0.263
F20-F29 Schizophrenia, schizotypal and delusional disorders	0.736	0.264
N60 Benign mammary dysplasia	0.736	0.264
F60-F69 Disorders of adult personality and behaviour	0.735	0.265
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.735	0.265
V49 Car occupant injured in other and unspecified transport accidents	0.735	0.265
Y42.6 Antigonadotrophins, antioestrogens, antiandrogens, not elsewhere classified	0.733	0.266
T43.5 Other and unspecified antipsychotics and neuroleptics	0.731	0.269
X65 Intentional self-poisoning by and exposure to alcohol	0.729	0.271
Y42.5 Other oestrogens and progestogens	0.729	0.271
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.728	0.272
S50.9 Superficial injury of forearm, unspecified	0.727	0.273
I80 Phlebitis and thrombophlebitis	0.727	0.273
R45 Symptoms and signs involving emotional state	0.727	0.273
N42.1 Congestion and haemorrhage of prostate	0.727	0.273
H60-H62 Diseases of external ear	0.726	0.274
Y54.3 Benzothiadiazine derivatives	0.725	0.275
A40 Streptococcal septicaemia	0.725	0.275
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.724	0.276
S56 Injury of muscle and tendon at forearm level	0.723	0.277
Q38-Q45 Other congenital malformations of the digestive system	0.723	0.277
T43.4 Butyrophenone and thioxanthene neuroleptics	0.722	0.278
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.722	0.278
I98 Other disorders of circulatory system in diseases classified elsewhere	0.721	0.278
N12 Tubulo-interstitial nephritis, not specified as acute or chronic	0.721	0.279
C30-C39 Malignant neoplasms of respiratory and intrathoracic organs	0.721	0.279
C45.7 Mesothelioma of other sites	0.720	0.280
X10-X19 Contact with heat and hot substances	0.720	0.280
T46.1 Calcium-channel blockers	0.717	0.283
B07 Viral warts	0.717	0.283
F32.0 Mild depressive episode	0.717	0.283
T33-T35 Frostbite	0.717	0.283
T26-T28 Burns and corrosions confined to eye and internal organs	0.717	0.283
Chapter XVI Certain conditions originating in the perinatal period	0.717	0.283
T46.5 Other antihypertensive drugs, not elsewhere classified	0.715	0.285
Y35-Y36 Legal intervention and operations of war	0.715	0.285
Y10-Y34 Event of undetermined intent	0.715	0.285
X85-X99 Assault	0.715	0.285
X30-X39 Exposure to forces of nature	0.715	0.285
X00-X09 Exposure to smoke, fire and flames	0.715	0.285
W85-W99 Exposure to electric current, radiation and extreme ambient air temperature and pressure	0.715	0.285
W75-W84 Other accidental threats to breathing	0.715	0.285
W65-W74 Accidental drowning and submersion	0.715	0.285
V98-V99 Other and unspecified transport accidents	0.715	0.285
V95-V97 Air and space transport accidents	0.715	0.285
V90-V94 Water transport accidents	0.715	0.285
V70-V79 Bus occupant injured in transport accident	0.715	0.285
V60-V69 Occupant of heavy transport vehicle injured in transport accident	0.715	0.285
V50-V59 Occupant of pick-up truck or van injured in transport accident	0.715	0.285
V30-V39 Occupant of three-wheeled motor vehicle injured in transport accident	0.715	0.285
F33.0 Recurrent depressive disorder, current episode mild	0.715	0.285
Y54.4 Loop [high-ceiling] diuretics	0.715	0.285
Q10-Q18 Congenital malformations of eye, ear, face and neck	0.714	0.286
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.713	0.286
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.713	0.286
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.713	0.286
T41 Poisoning by anaesthetics and therapeutic gases	0.713	0.286
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.713	0.286
T36 Poisoning by systemic antibiotics	0.713	0.286
Y45 Analgesics, antipyretics and anti-inflammatory drugs	0.713	0.287
S42.1 Fracture of scapula	0.712	0.288
B01 Varicella [chickenpox]	0.712	0.288
B49 Unspecified mycosis	0.710	0.290
S42.2 Fracture of upper end of humerus	0.710	0.290
F33.3 Recurrent depressive disorder, current episode severe with psychotic symptoms	0.709	0.291
Y51.7 Beta-Adrenoreceptor antagonists, not elsewhere classified	0.709	0.291
Y70-Y82 Medical devices associated with adverse incidents in diagnostic and therapeutic use	0.708	0.292
V44 Car occupant injured in collision with heavy transport vehicle or bus	0.708	0.292
F32.9 Depressive episode, unspecified	0.708	0.292
I85.9 Oesophageal varices without bleeding	0.707	0.293
N64.1 Fat necrosis of breast	0.707	0.293
D45 Polycythaemia vera	0.706	0.294
I80.2 Phlebitis and thrombophlebitis of other deep vessels of lower extremities	0.706	0.294
C95 Leukaemia of unspecified cell type	0.706	0.294
T46.4 Angiotensin-converting-enzyme inhibitors	0.705	0.294
X78 Intentional self-harm by sharp object	0.704	0.296
D47.1 Chronic myeloproliferative disease	0.704	0.296
D48 Neoplasm of uncertain or unknown behaviour of other and unspecified sites	0.703	0.297
X20-X29 Contact with venomous animals and plants	0.703	0.297
B20-B24 Human immunodeficiency virus [HIV] disease	0.703	0.297
I30-I52 Other forms of heart disease	0.703	0.297
I60.2 Subarachnoid haemorrhage from anterior communicating artery	0.703	0.297
S10-S19 Injuries to the neck	0.703	0.297
N42.8 Other specified disorders of prostate	0.703	0.297
X50-X57 Overexertion, travel and privation	0.702	0.297
Y59 Other and unspecified vaccines and biological substances	0.702	0.298
Y58 Bacterial vaccines	0.702	0.298
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system	0.702	0.298
Y53 Agents primarily affecting the gastro-intestinal system	0.702	0.298
Y50 Central nervous system stimulants, not elsewhere classified	0.702	0.298
Y49 Psychotropic drugs, not elsewhere classified	0.702	0.298
Y47 Sedatives, hypnotics and antianxiety drugs	0.702	0.298
Y46 Antiepileptics and anti-Parkinsonism drugs	0.702	0.298
N03.9 Unspecified	0.701	0.299
B85-B89 Pediculosis, acariasis and other infestations	0.701	0.299
A92-A99 Arthropod-borne viral fevers and viral haemorrhagic fevers	0.701	0.299
A75-A79 Rickettsioses	0.701	0.299
A70-A74 Other diseases caused by chlamydiae	0.701	0.299
A65-A69 Other spirochaetal diseases	0.701	0.299
A20-A28 Certain zoonotic bacterial diseases	0.701	0.299
A15-A19 Tuberculosis	0.701	0.299
R40 Somnolence, stupor and coma	0.699	0.301
B02.3 Zoster ocular disease	0.699	0.301
N18.1 Chronic kidney disease, stage 1	0.699	0.301
C64-C68 Malignant neoplasms of urinary tract	0.698	0.302
F81 Specific developmental disorders of scholastic skills	0.697	0.303
D47.3 Essential (haemorrhagic) thrombocythaemia	0.697	0.303
X68 Intentional self-poisoning by and exposure to pesticides	0.696	0.304
C14 Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx	0.696	0.304
F39 Unspecified mood [affective] disorder	0.695	0.305
R23 Other skin changes	0.695	0.305
Chapter XXII Codes for special purposes	0.694	0.305
S51.9 Open wound of forearm, part unspecified	0.694	0.306
H81.2 Vestibular neuronitis	0.694	0.306
C81.1 Nodular sclerosis	0.694	0.306
T68 Hypothermia	0.693	0.307
T75 Effects of other external causes	0.693	0.307
T29-T32 Burns and corrosions of multiple and unspecified body regions	0.693	0.307
T66 Unspecified effects of radiation	0.692	0.307
D44 Neoplasm of uncertain or unknown behaviour of endocrine glands	0.692	0.308
C09 Malignant neoplasm of tonsil	0.692	0.308
C92.0 Acute myeloid leukaemia	0.691	0.309
S59 Other and unspecified injuries of forearm	0.691	0.309
S58 Traumatic amputation of forearm	0.691	0.309
S57 Crushing injury of forearm	0.691	0.309
S55 Injury of blood vessels at forearm level	0.691	0.309
S54 Injury of nerves at forearm level	0.691	0.309
D40 Neoplasm of uncertain or unknown behaviour of male genital organs	0.690	0.310
S43.1 Dislocation of acromioclavicular joint	0.689	0.311
Q50-Q56 Congenital malformations of genital organs	0.689	0.311
C60-C63 Malignant neoplasms of male genital organs	0.689	0.311
T21 Burn and corrosion of trunk	0.688	0.312
C06 Malignant neoplasm of other and unspecified parts of mouth	0.687	0.313
S51.0 Open wound of elbow	0.687	0.313
Y43.1 Antineoplastic antimetabolites	0.687	0.313
C88 Malignant immunoproliferative diseases	0.686	0.314
I86 Varicose veins of other sites	0.686	0.314
X59 Exposure to unspecified factor	0.686	0.314
S48 Traumatic amputation of shoulder and upper arm	0.686	0.314
S45 Injury of blood vessels at shoulder and upper arm level	0.686	0.314
S44 Injury of nerves at shoulder and upper arm level	0.686	0.314
S47 Crushing injury of shoulder and upper arm	0.686	0.314
Y90-Y98 Supplementary factors related to causes of morbidity and mortality classified elsewhere	0.685	0.315
W50-W64 Exposure to animate mechanical forces	0.685	0.315
B08 Other viral infections characterised by skin and mucous membrane lesions, not elsewhere classified	0.685	0.315
F90-F98 Behavioural and emotional disorders with onset usually occurring in childhood and adolescence	0.684	0.316
F70-F79 Mental retardation	0.684	0.316
T65 Toxic effect of other and unspecified substances	0.684	0.316
T62 Toxic effect of other noxious substances eaten as food	0.684	0.316
T61 Toxic effect of noxious substances eaten as seafood	0.684	0.316
T60 Toxic effect of pesticides	0.684	0.316
T57 Toxic effect of other inorganic substances	0.684	0.316
T56 Toxic effect of metals	0.684	0.316
T54 Toxic effect of corrosive substances	0.684	0.316
T53 Toxic effect of halogen derivatives of aliphatic and aromatic hydrocarbone	0.684	0.316
T52 Toxic effect of organic solvents	0.684	0.316
T64 Toxic effect of aflatoxin and other mycotoxin food contaminants	0.684	0.316
T55 Toxic effect of soaps and detergents	0.684	0.316
N43 Hydrocele and spermatocele	0.683	0.317
Chapter VII Diseases of the eye and adnexa	0.683	0.317
S92.20 Fracture of other tarsal bone(s) (closed)	0.682	0.318
N11 Chronic tubulo-interstitial nephritis	0.682	0.318
B99-B99 Other infectious diseases	0.681	0.318
C45.9 Mesothelioma, unspecified	0.681	0.319
S80.0 Contusion of knee	0.680	0.320
A04.8 Other specified bacterial intestinal infections	0.680	0.320
S98 Traumatic amputation of ankle and foot	0.679	0.321
S97 Crushing injury of ankle and foot	0.679	0.321
S96 Injury of muscle and tendon at ankle and foot level	0.679	0.321
S95 Injury of blood vessels at ankle and foot level	0.679	0.321
S94 Injury of nerves at ankle and foot level	0.679	0.321
S92.30 Fracture of metatarsal bone (closed)	0.679	0.321
D80-D89 Certain disorders involving the immune mechanism	0.679	0.321
Y44 Agents primarily affecting blood constituents	0.678	0.321
W10 Fall on and from stairs and steps	0.678	0.322
I35 Nonrheumatic aortic valve disorders	0.678	0.322
C00 Malignant neoplasm of lip	0.677	0.323
V09 Pedestrian injured in other and unspecified transport accidents	0.677	0.323
A44 Bartonellosis	0.675	0.325
A43 Nocardiosis	0.675	0.325
A42 Actinomycosis	0.675	0.325
A39 Meningococcal infection	0.675	0.325
A37 Whooping cough	0.675	0.325
A36 Diphtheria	0.675	0.325
A32 Listeriosis	0.675	0.325
A31 Infection due to other mycobacteria	0.675	0.325
A30 Leprosy [Hansen's disease]	0.675	0.325
A38 Scarlet fever	0.675	0.325
A35 Other tetanus	0.675	0.325
A34 Obstetrical tetanus	0.675	0.325
A33 Tetanus neonatorum	0.675	0.325
X63 Intentional self-poisoning by and exposure to other drugs acting on the autonomic nervous system	0.675	0.325
T40.4 Other synthetic narcotics	0.675	0.325
F33.1 Recurrent depressive disorder, current episode moderate	0.675	0.325
S91 Open wound of ankle and foot	0.674	0.326
B37 Candidiasis	0.674	0.326
V80-V89 Other land transport accidents	0.674	0.326
S41.1 Open wound of upper arm	0.673	0.326
F10.0 Acute intoxication	0.673	0.327
C73 Malignant neoplasm of thyroid gland	0.673	0.327
C49 Malignant neoplasm of other connective and soft tissue	0.672	0.328
H49-H52 Disorders of ocular muscles, binocular movement, accommodation and refraction	0.672	0.328
N99-N99 Other disorders of the genitourinary system	0.671	0.329
Chapter X Diseases of the respiratory system	0.671	0.329
T23 Burn and corrosion of wrist and hand	0.671	0.329
B15-B19 Viral hepatitis	0.671	0.329
T59 Toxic effect of other gases, fumes and vapours	0.670	0.329
T50.9 Other and unspecified drugs, medicaments and biological substances	0.670	0.330
C85.9 Non-Hodgkin's lymphoma, unspecified type	0.670	0.330
D70-D77 Other diseases of blood and blood-forming organs	0.668	0.332
T51.8 Other alcohols	0.667	0.333
T51.3 Fusel oil	0.667	0.333
T51.2 2-Propanol	0.667	0.333
T51.1 Methanol	0.667	0.333
I65.0 Occlusion and stenosis of vertebral artery	0.667	0.333
N18.4 Chronic kidney disease, stage 4	0.666	0.334
I00-I02 Acute rheumatic fever	0.666	0.334
T58 Toxic effect of carbon monoxide	0.666	0.334
F31 Bipolar affective disorder	0.665	0.335
T78 Adverse effects, not elsewhere classified	0.665	0.335
C85.1 B-cell lymphoma, unspecified	0.665	0.335
H82 Vertiginous syndromes in diseases classified elsewhere	0.665	0.335
S93 Dislocation, sprain and strain of joints and ligaments at ankle and foot level	0.664	0.336
T15-T19 Effects of foreign body entering through natural orifice	0.664	0.336
D37.5 Rectum	0.664	0.336
T93 Sequelae of injuries of lower limb	0.664	0.336
I98.2 Oesophageal varices in diseases classified elsewhere	0.662	0.338
C12 Malignant neoplasm of pyriform sinus	0.662	0.338
Q90-Q99 Chromosomal abnormalities, not elsewhere classified	0.661	0.338
Q35-Q37 Cleft lip and cleft palate	0.661	0.338
Q30-Q34 Congenital malformations of the respiratory system	0.661	0.338
C40-C41 Malignant neoplasms of bone and articular cartilage	0.661	0.339
W20-W49 Exposure to inanimate mechanical forces	0.661	0.339
S92.00 Fracture of calcaneus (closed)	0.660	0.340
N42.0 Calculus of prostate	0.660	0.340
I60.1 Subarachnoid haemorrhage from middle cerebral artery	0.660	0.340
Y52 Agents primarily affecting the cardiovascular system	0.660	0.340
S80.9 Superficial injury of lower leg, unspecified	0.660	0.340
R45.8 Other symptoms and signs involving emotional state	0.660	0.340
N51 Disorders of male genital organs in diseases classified elsewhere	0.659	0.341
N44 Torsion of testis	0.659	0.341
A41.0 Septicaemia due to Staphylococcus aureus	0.659	0.341
F38 Other mood [affective] disorders	0.659	0.341
F34 Persistent mood [affective] disorders	0.659	0.341
N60.4 Mammary duct ectasia	0.658	0.342
S90.9 Superficial injury of ankle and foot, unspecified	0.658	0.342
N70-N77 Inflammatory diseases of female pelvic organs	0.657	0.343
N45 Orchitis and epididymitis	0.657	0.343
I70-I79 Diseases of arteries, arterioles and capillaries	0.657	0.343
I68 Cerebrovascular disorders in diseases classified elsewhere	0.657	0.343
I66 Occlusion and stenosis of cerebral arteries, not resulting in cerebral infarction	0.657	0.343
B06 Rubella [German measles]	0.656	0.344
B05 Measles	0.656	0.344
B09 Unspecified viral infection characterised by skin and mucous membrane lesions	0.656	0.344
B04 Monkeypox	0.656	0.344
B03 Smallpox	0.656	0.344
W18 Other fall on same level	0.654	0.346
I63 Cerebral infarction	0.654	0.346
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.652	0.348
B00 Herpesviral [herpes simplex] infections	0.652	0.348
H52 Disorders of refraction and accommodation	0.652	0.348
A80-A89 Viral infections of the central nervous system	0.651	0.349
I95 Hypotension	0.651	0.349
A04.7 Enterocolitis due to Clostridium difficile	0.651	0.349
N50.9 Disorder of male genital organs, unspecified	0.650	0.350
B35 Dermatophytosis	0.649	0.351
N05 Unspecified nephritic syndrome	0.648	0.352
S92.5 Fracture of other toe	0.648	0.352
Y54.9 Mineral salts, not elsewhere classified	0.647	0.352
Y54.8 Agents affecting uric acid metabolism	0.647	0.352
Y54.7 Agents affecting calcification	0.647	0.352
Y54.6 Electrolytic, caloric and water-balance agents	0.647	0.352
Y54.2 Carbonic-anhydrase inhibitors	0.647	0.352
Y54.1 Mineralocorticoid antagonists [aldosterone antagonists]	0.647	0.352
Y54.0 Mineralocorticoids	0.647	0.352
I67.1 Cerebral aneurysm, nonruptured	0.646	0.354
B36 Other superficial mycoses	0.646	0.354
S92.9 Fracture of foot, unspecified	0.645	0.355
S92.7 Multiple fractures of foot	0.645	0.355
S92.4 Fracture of great toe	0.645	0.355
S92.1 Fracture of talus	0.645	0.355
S53.3 Traumatic rupture of ulnar collateral ligament	0.645	0.355
T08-T14 Injuries to unspecified part of trunk, limb or body region	0.645	0.355
W06 Fall involving bed	0.645	0.355
C10 Malignant neoplasm of oropharynx	0.644	0.356
N60.2 Fibroadenosis of breast	0.644	0.356
C97-C97 Malignant neoplasms of independent (primary) multiple sites	0.643	0.357
F30 Manic episode	0.643	0.357
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.643	0.357
T40.8 Lysergide [LSD]	0.643	0.357
T40.7 Cannabis (derivatives)	0.643	0.357
T40.5 Cocaine	0.643	0.357
T40.3 Methadone	0.643	0.357
T40.1 Heroin	0.643	0.357
T40.0 Opium	0.643	0.357
Y43.4 Immunosuppressive agents	0.642	0.358
V23 Motorcycle rider injured in collision with car, pick-up truck or van	0.642	0.358
N49.2 Inflammatory disorders of scrotum	0.641	0.359
D47.2 Monoclonal gammopathy	0.641	0.359
T79.3 Post-traumatic wound infection, not elsewhere classified	0.641	0.359
S99 Other and unspecified injuries of ankle and foot	0.639	0.361
Q00-Q07 Congenital malformations of the nervous system	0.638	0.362
R82 Other abnormal findings in urine	0.638	0.362
S22 Fracture of rib(s), sternum and thoracic spine	0.638	0.362
R43 Disturbances of smell and taste	0.637	0.363
D37.6 Liver, gallbladder and bile ducts	0.637	0.363
X84 Intentional self-harm by unspecified means	0.637	0.363
X83 Intentional self-harm by other specified means	0.637	0.363
X82 Intentional self-harm by crashing of motor vehicle	0.637	0.363
X81 Intentional self-harm by jumping or lying before moving object	0.637	0.363
X80 Intentional self-harm by jumping from a high place	0.637	0.363
X79 Intentional self-harm by blunt object	0.637	0.363
X77 Intentional self-harm by steam, hot vapours and hot objects	0.637	0.363
X76 Intentional self-harm by smoke, fire and flames	0.637	0.363
X75 Intentional self-harm by explosive material	0.637	0.363
X74 Intentional self-harm by other and unspecified firearm discharge	0.637	0.363
X73 Intentional self-harm by rifle, shotgun and larger firearm discharge	0.637	0.363
X72 Intentional self-harm by handgun discharge	0.637	0.363
X71 Intentional self-harm by drowning and submersion	0.637	0.363
X70 Intentional self-harm by hanging, strangulation and suffocation	0.637	0.363
X69 Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances	0.637	0.363
X67 Intentional self-poisoning by and exposure to other gases and vapours	0.637	0.363
X66 Intentional self-poisoning by and exposure to organic solvents and halogenated hydrocarbons and their vapours	0.637	0.363
X64 Intentional self-poisoning by and exposure to other and unspecified drugs, medicaments and biological substances	0.637	0.363
X61 Intentional self-poisoning by and exposure to antiepileptic, sedative-hypnotic, anti-Parkinsonism and psychotropic drugs, not elsewhere classified	0.637	0.363
X60 Intentional self-poisoning by and exposure to nonopioid analgesics, antipyretics and antirheumatics	0.637	0.363
X45 Accidental poisoning by and exposure to alcohol	0.636	0.364
S40 Superficial injury of shoulder and upper arm	0.636	0.364
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.636	0.364
T46.8 Antivaricose drugs, including sclerosing agents	0.636	0.364
T46.7 Peripheral vasodilators	0.636	0.364
T46.3 Coronary vasodilators, not elsewhere classified	0.636	0.364
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.636	0.364
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.636	0.364
S83 Dislocation, sprain and strain of joints and ligaments of knee	0.636	0.364
C47 Malignant neoplasm of peripheral nerves and autonomic nervous system	0.635	0.365
C46 Kaposi's sarcoma	0.635	0.365
I67.7 Cerebral arteritis, not elsewhere classified	0.635	0.365
I67.6 Nonpyogenic thrombosis of intracranial venous system	0.635	0.365
I67.5 Moyamoya disease	0.635	0.365
I67.4 Hypertensive encephalopathy	0.635	0.365
I67.3 Progressive vascular leukoencephalopathy	0.635	0.365
I67.0 Dissection of cerebral arteries, nonruptured	0.635	0.365
R40.0 Somnolence	0.635	0.365
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.634	0.366
C94 Other leukaemias of specified cell type	0.634	0.366

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations